Related Articles
Clinical significance of immunohistochemical Bcl-2 expression in invasive breast carcinoma.
Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy
Low apoptotic activity in primary prostate carcinomas without response to hormonal therapy.
Targeted therapy in HER2‑positive breast cancer (Review)
Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms